Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-28T15:36:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T18:14:35.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T17:33:54.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T18:08:44.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the usual study content and indicating restricted access to the record.
    Difference
    21%
    Check dated 2026-09-23T21:43:27.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.6 to v3.7.0, indicating a new version of the page content.
    Difference
    0.0%
    Check dated 2026-09-16T22:19:47.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.